ELK1 and neoplasm: The study also described that human tissue plasminogen activator (tPA) is a target of ELK1-mediated gene transcription [99], further supporting the notion of ELK1 targeting as part of anticancer therapies, given the pro-tumor roles attributed to Plasminogen activator, tissue type (tPA or PLAT).